Jawhar Rawwas

581 total citations
11 papers, 245 citations indexed

About

Jawhar Rawwas is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jawhar Rawwas has authored 11 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Neurology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jawhar Rawwas's work include Neuroblastoma Research and Treatments (6 papers), Cancer therapeutics and mechanisms (5 papers) and Retinoids in leukemia and cellular processes (2 papers). Jawhar Rawwas is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Cancer therapeutics and mechanisms (5 papers) and Retinoids in leukemia and cellular processes (2 papers). Jawhar Rawwas collaborates with scholars based in United States, Australia and France. Jawhar Rawwas's co-authors include Anu Gupta, Bryan Williams, Samir Hanash, Ioannis G. Koutlas, Deanna Mitchell, Barry L. Shulkin, David Ungar, Mukund Dole, Valerie P. Castle and Patricia Kessler and has published in prestigious journals such as Cancer Research, International Journal of Cancer and Experimental Cell Research.

In The Last Decade

Jawhar Rawwas

11 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jawhar Rawwas United States 8 130 89 67 44 39 11 245
Barbara Scepura United States 6 113 0.9× 114 1.3× 29 0.4× 39 0.9× 84 2.2× 8 292
Xingyun Su China 11 161 1.2× 23 0.3× 79 1.2× 25 0.6× 77 2.0× 20 401
Patricia Pastura United States 9 82 0.6× 50 0.6× 23 0.3× 101 2.3× 62 1.6× 13 320
Daisuke Shintani Japan 10 84 0.6× 21 0.2× 76 1.1× 50 1.1× 82 2.1× 34 293
Tina Catela Ivković Croatia 12 207 1.6× 31 0.3× 156 2.3× 42 1.0× 119 3.1× 25 416
Emilia Alors‐Pérez Spain 10 230 1.8× 38 0.4× 78 1.2× 50 1.1× 61 1.6× 23 353
Sébastien Hergalant France 11 159 1.2× 12 0.1× 57 0.9× 21 0.5× 32 0.8× 26 320
Yu-Kai Su Taiwan 10 162 1.2× 53 0.6× 85 1.3× 57 1.3× 94 2.4× 14 340
Makoto Edagawa Japan 10 117 0.9× 21 0.2× 42 0.6× 103 2.3× 87 2.2× 28 329
Deborah Witte United States 7 114 0.9× 21 0.2× 53 0.8× 51 1.2× 104 2.7× 9 324

Countries citing papers authored by Jawhar Rawwas

Since Specialization
Citations

This map shows the geographic impact of Jawhar Rawwas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jawhar Rawwas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jawhar Rawwas more than expected).

Fields of papers citing papers by Jawhar Rawwas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jawhar Rawwas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jawhar Rawwas. The network helps show where Jawhar Rawwas may publish in the future.

Co-authorship network of co-authors of Jawhar Rawwas

This figure shows the co-authorship network connecting the top 25 collaborators of Jawhar Rawwas. A scholar is included among the top collaborators of Jawhar Rawwas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jawhar Rawwas. Jawhar Rawwas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhou, Shenghua, John Gross, Ying Zou, et al.. (2025). RAS pathway targeted therapy in patients with DICER1-associated sarcomas. npj Precision Oncology. 9(1). 232–232. 1 indexed citations
2.
Eslin, Don, Peter E. Zage, Genevieve Bergendahl, et al.. (2023). A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma. International Journal of Cancer. 153(5). 1026–1034. 5 indexed citations
3.
Argani, Pedram, L. Jeffrey Medeiros, Andrés Matoso, et al.. (2023). “Oncocytoid Renal Cell Carcinomas After Neuroblastoma” Represent TSC-mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas. The American Journal of Surgical Pathology. 47(12). 1335–1348. 9 indexed citations
4.
Koutlas, Ioannis G., et al.. (2020). FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones. Head and Neck Pathology. 15(1). 374–380. 25 indexed citations
5.
Lewis, Elizabeth C., Jacqueline M. Kraveka, William S. Ferguson, et al.. (2020). A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma. International Journal of Cancer. 147(11). 3152–3159. 45 indexed citations
6.
Rawwas, Jawhar, et al.. (2018). Hepatosplenic γδ T‐cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults. Pediatric Transplantation. 22(5). e13213–e13213. 5 indexed citations
7.
Pinto, Navin, Gordana Raca, Mark A. Applebaum, et al.. (2016). Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin‐Fixed Paraffin‐Embedded Tissue Samples and Are Associated With Recurrence. Pediatric Blood & Cancer. 63(6). 1019–1023. 17 indexed citations
8.
Gupta, Anu, Patricia Kessler, Jawhar Rawwas, & Bryan Williams. (2008). Regulation of CRABP-II expression by MycN in Wilms tumor. Experimental Cell Research. 314(20). 3663–3668. 25 indexed citations
9.
Gupta, Anu, Bryan Williams, Samir Hanash, & Jawhar Rawwas. (2006). Cellular Retinoic Acid–Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma. Cancer Research. 66(16). 8100–8108. 41 indexed citations
10.
Chen, Chun‐Lin, et al.. (2001). Bioavailability and Pharmacokinetic Features of Etoposide in Childhood Acute Lymphoblastic Leukemia Patients. Leukemia & lymphoma. 42(3). 317–327. 15 indexed citations
11.
Shulkin, Barry L., Donald M. Wieland, David Ungar, et al.. (1996). PET hydroxyephedrine imaging of neuroblastoma.. PubMed. 37(1). 16–21. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026